Risk of cardiovascular events associated with COX-2 inhibitors

被引：0
|
作者：
不详
机构：
来源：
HOSPITAL MEDICINE | 2001年 / 62卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：577 / 577
页数：1
相关论文
共 50 条
  • [1] Risk of cardiovascular events associated with selective COX-2 inhibitors
    Mukherjee, D
    Nissen, SE
    Topol, EJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (08): : 954 - 959
  • [2] Cardiovascular events and COX-2 inhibitors
    Singh, G
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (22): : 2810 - 2811
  • [3] Cardiovascular Risk Associated With NSAIDs and COX-2 Inhibitors
    Perry, Laura A.
    Mosier, Charles
    Atkins, Ashton
    Minehart, Megan
    [J]. US PHARMACIST, 2014, 39 (03) : 35 - 38
  • [4] COX-2 inhibitors and cardiovascular risk
    Funk, Colin D.
    FitzGerald, Garret A.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (05) : 470 - 479
  • [5] COX-2 Inhibitors and Cardiovascular Risk
    Cannon, Christopher P.
    Cannon, Paul J.
    [J]. SCIENCE, 2012, 336 (6087) : 1386 - 1387
  • [6] COX-2 inhibitors and risks for cardiovascular events
    Kazuki Takada
    [J]. Arthritis Research & Therapy, 3 (1)
  • [7] Why do COX-2 inhibitors increase risk of cardiovascular events?
    Frankish, H
    [J]. LANCET, 2002, 359 (9315): : 1410 - 1410
  • [8] Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
    Debabrata Mukherjee
    Eric J Topol
    [J]. Arthritis Res Ther, 5
  • [9] Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events
    Mukherjee, D
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 63 (05) : 817 - 821
  • [10] COX-2 inhibitors: increased risk of CV events?
    [J]. Reactions Weekly, 2001, 867 (1) : 2 - 2
12345